BioSpace News Archive

The company’s technology is designed to attach any off-the-shelf antibody with any payload without the need for modification.

As Johnson & Johnson touted $23.3 billion sales on its Q2 earnings call this morning, other news in the media hasn’t been as kind to the massive, global conglomerate.

The FDA placed a clinical hold on Magenta’s clinical program for acute myeloid leukemia and myelodysplastic syndrome, which made its shares drop nearly 7% this morning.

The study will also investigate the oral combination with PD-1 inhibitor pembrolizumab in EBV+ metastatic nasopharyngeal carcinoma (RM-NPC).

The life science Group Sartorius has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake.

Revolutionary technologies and cutting-edge research have led to the development of numerous innovative medical equipment, enabling patients to live healthier and longer.

The demand within the global MRI coils market is rising at a sturdy pace in recent times. The use of MRI coils has become a necessity for ensuring proper functioning of MRI machines.

AbbVie announced that the U.S. Food and Drug Administration granted a Breakthrough Therapy Designation to venetoclax in combination with azacitidine for the potential treatment of adult patients with previously untreated intermediate-, high- and very high-risk myelodysplastic syndromes based on revised International Prognostic Scoring System.

Sartorius Stedim Biotech, a leading partner of the biopharma industry, has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake.

Pharmacovigilance has evolved considerably thanks to strict monitoring in place jointly by the pharma consortium and regulatory bodies in several parts of the world.